Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review

Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review

Gender-neutral vaccination (GNV) of human papillomavirus (HPV) may help reduce the transmission and incidence of HPV-related diseases. However, approximately 40 countries have implemented HPV GNV schedules. We systematically evaluated HPV GNV cost-effectiveness models from January 2008 to May 2024 u...

Full description

Saved in:
Bibliographic Details
Main Authors: Marisa Felsher, Marcie Fisher-Borne, Tufail Malik, Nita Santpurkar, Stephan Martin, Omer Zaidi, Wei Wang, Cody Palmer
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Human papillomavirus
cervical cancer
screening
vaccination
intervention
cost-effectiveness
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2516322
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2025.2516322

Similar Items